Therapeutic Areas
Neurology/Psychiatry
Accelerate Your Novel Neurology/Psychiatry Therapies to Approval and Commercial Success.
Second to Cancer, Neurology clinical trials are incredibly complex and complicated to navigate. At Veristat, we have assembled an extraordinary team of scientific experts who have mastered the complexities of running Neurology trials. In the past five years, our team has supported more than 200 clinical trials and consulting projects for neurology therapies, including neurodegenerative disorders, pain management, and mental health disorders.
Trust Veristat to guide your success in mitigating risks and efficiently bring your therapy toward its next development milestone, all while ensuring patient safety and access.
Developing a neurological therapy?
Neurology, Pain Management, and Psychiatry Experience in the Past 5 Years
+0
clinical trials & consulting projects in the past 5 years
0%
for rare/ultra-rare neurological disorders
0%
of global operations team members have neurology and psychiatry experience
Connect with a Neurology Expert Today.
We know there are always unknown challenges when bringing a novel therapeutics to market, so we’ve assembled an extraordinary team of scientific minded experts who have mastered the complexities of therapeutic development enabling sponsors to succeed in extending and saving lives.
Clinical Trial and Regulatory Consulting Expertise for Neurology
Our expertise allows us to confidently handle the most complex trials and patient populations with the attention and focus needed to navigate the CNS neurology landscape.
Whatever your challenges are, Veristat provides creative and strategic approaches to inform your decision-making, mitigate trial risks, prove safety and efficacy, and achieve approval success. Our regulatory and clinical development experts are poised to launch your CNS/Neurology trial:
-
Pre-Clinical/Trial Planning to increase speed
-
Study Design and Methodology that works
-
Development of regulatory strategy, expedited pathways, and regulatory agency interactions
-
Clinical program planning, inclusive of statistical planning and analysis
-
Agile patient recruitment strategies to support virtual trial and hybrid approaches
-
Post-Market Pharmacovigilance Ensure Safety
Case Study: Global Pediatric Full-Service Phase I/II Clinical Trial for Rare Neurological Disease Begins
A mid-sized biotech company sought Veristat early in development for help with a Natural History trial. After its successful implementation, the sponsor moved forward with the gene therapy treatment program, which has already treated its first patients. Learn how Veristat serves as an implementation arm of the sponsor and continues to provide full-service support for this Phase 1/2 clinical trial.
Scientific Excellence Across Neurology Therapy Development
Neurological Disorders
Amyotrophic Lateral Sclerosis
Canavan Disease
Friedreich's Ataxia
Migraine
Multiple Sclerosis (MS)
Parkinson's Disease
and more...
Psychiatry
- Autism Spectrum Disorder
Depression - Mood Disorders
- Post-Traumatic Stress Disorder
Smoking Cessation
Substance Abuse Disorder
Schizophrenia
and more...
Pain Management
- Acute Pain
- Chronic Pain
- Osteoarthritis Joint Pain
- Opioid and Non-Opioid
- Post-Surgical Pain
- And more...
Learn More with These Resources
Infographic
A Practical Guide for Managing Multiple Global Regulatory ...
Infographic
FDA Expedited Programs – What You Need to Know
Fact Sheet
Side-by-Side Comparison: Non-Adaptive vs. Adaptive Designs in ...